In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated.
You May Also Like
- Parkinson's disease: progressive and clinically heterogeneous
Individualized management of motor and non-motor symptoms
- Type 2 diabetes and heart failure: a bidirectional relationship
Proactive preventive measures can reduce the burden of disease
- Dementia
Delirium risks and treatment strategies
- Colorectal cancer screening
Results of the population-based PREEMPT-CRC study
- Study report: TBS v3 and v4 in comparison
Analysis of OsteoLaus study data
- Atopic dermatitis: proven therapeutic principles and innovations
From healthcare research to precision medicine
- SGLT2 inhibitors and glucocorticoids
Protective effect on kidney function is maintained
- Study report: Nicotinamide for skin cancer prevention